Farmak has been included in the Top 50 Companies with the Strongest Reputation Capital according to the TOP-100. Ratings of the Largest and the business portal Delo.ua, becoming the only pharmaceutical company in Ukraine to enter this year’s ranking.
The selection process combined the results of online voting by Delo.ua readers and evaluations from an expert jury. Companies were assessed on the strength of their reputation management, quality of PR, resilience to information attacks, consumer loyalty, involvement in CSR projects, and charitable initiatives. The evaluation also considered employer brand strength, transparency in communications with investors and partners, and the quality of government relations (GR).
Nearly 150 companies operating in Ukraine and well known to consumers and the business community participated in the ranking. The final list includes representatives from 16 key sectors of the economy, including banking, retail, agriculture, FMCG, mining and metals, and pharmaceuticals.
For 15 consecutive years, Farmak has remained the undisputed leader of the Ukrainian pharmaceutical market, exporting its products to more than 60 countries and maintaining a portfolio of over 450 medicinal products. All medicines are manufactured in accordance with European GMP (Good Manufacturing Practice) standards. Each year, the company reinvests up to 90% of its profits in development: research and development of new medicines, construction of production facilities, and technological modernization.
“Farmak celebrates its 100th anniversary this year. Over the decades, we have lived through financial crises, revolutions, shifts in political regimes, economic transformations, and wars. We have endured and continued to move forward only because we have always worked with integrity, responsibility, and an unwavering focus on quality. These are fundamental values without which it is impossible to build a sustainable business and a genuine reputation,” said Alla Pozychaniuk, Head of PR at Farmak.
The full ranking is available at the link.
